GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (XSWX:GALD) » Definitions » Dividends per Share

Galderma Group AG (XSWX:GALD) Dividends per Share : CHF0.00 (TTM As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Dividends per Share?

Galderma Group AG's dividends per share for the six months ended in Jun. 2024 was CHF0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jun. 2024 was CHF0.00. Its Dividend Payout Ratio for the six months ended in Jun. 2024 was 0.00. As of today, Galderma Group AG's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Galderma Group AG Dividends per Share Historical Data

The historical data trend for Galderma Group AG's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Dividends per Share Chart

Galderma Group AG Annual Data
Trend
Dividends per Share

Galderma Group AG Semi-Annual Data
Jun23 Jun24
Dividends per Share - -

Competitive Comparison of Galderma Group AG's Dividends per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galderma Group AG's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Galderma Group AG's Dividend Yield % falls into.



Galderma Group AG Dividends per Share Calculation

Dividends paid to per common share.


Galderma Group AG  (XSWX:GALD) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Galderma Group AG's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2024 )/ EPS without NRI (Q: Jun. 2024 )
=0/ 0.186
=0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Galderma Group AG Dividends per Share Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Galderma Group AG Business Description

Comparable Companies
Traded in Other Exchanges
Address
Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines